IXICO plc (AIM:IXI)

Market Cap	7.27M -31.7%
Revenue (ttm)	6.53M +13.3%
Net Income	-1.65M
EPS	-0.02
Shares Out	92.67M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	702,923
Average Volume	255,526
Open	7.75
Previous Close	7.75
Day's Range	7.60 - 8.10
52-Week Range	7.00 - 15.00
Beta	0.40
RSI	17.81
Earnings Date	Dec 9, 2025

About IXICO

IXICO plc provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally. The company offers collection, analysis, management, and reporting on gathered clinical study data; neurological diseases data collection and analysis; and sales and marketing services. It also provides imaging contract research organization solutions, including imaging biomarkers, such as radiological reads, volumetric MRI, PET and SPECT, and advanced MRI...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 79
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: IXI

Financial Performance

In fiscal year 2025, IXICO's revenue was 6.53 million, an increase of 13.32% compared to the previous year's 5.77 million. Losses were -1.65 million, -17.49% less than in 2024.